等待开盘 12-15 09:30:00 美东时间
+0.370
+0.85%
今日重点评级关注:RBC Capital:上调Neumora Therapeutics评级至"跑赢大市",目标价从4美元升至7美元;HC Wainwright & Co.:维持ProMIS Neurosciences"买入"评级,目标价从4美元升至18美元
12-02 09:50
Barrington Research analyst Alexander Paris maintains Carriage Servs (NYSE:CSV) with a Outperform and maintains $60 price target.
12-01 20:35
Carriage Servs (NYSE:CSV) reported quarterly earnings of $0.75 per share which beat the analyst consensus estimate of $0.73 by 2.32 percent. This is a 17.19 percent increase over earnings of $0.64 per share from the same
11-06 05:51
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
今日重点评级关注:摩根士丹利:维持Viking Therapeutics"超配"评级,目标价从98美元升至102美元;摩根大通:维持IDEAYA Biosciences"超配"评级,目标价从74美元升至79美元
10-24 09:51
Barrington Research analyst Alexander Paris maintains Carriage Servs (NYSE:CSV) with a Outperform and maintains $60 price target.
10-24 00:28
Carriage (NYSE:CSV) declares $0.1125/share quarterly dividend, in line with previous. Forward yield 1.0% Payable Dec. 1; for shareholders of record Nov. 3; ex-div Nov. 3. See CSV Dividend Scorecard, Y...
10-16 05:53
Dashlane integration with FIDO2 YubiKeys gives new Dashlane users the strongest available protection for vault access and encryption with device-bound passkeys, replacing the master password...
10-14 21:05
(来源:知危) Agent、Agnet?Agent!说起今年的 AI 浪潮,除了年初 DeepSeek 引领的一波强化学习热,行业内最受关注的,莫过于各种各...
10-14 18:56
今日重点评级关注:Maxim Group:维持Kazia Therapeutics"买入"评级,目标价从15美元升至20美元;Baird:维持Taysha Gene Therapies"跑赢大市"评级,目标价从7美元升至12美元
10-03 14:32